Endocrine profile of the pituitary-gonadal axis in male patients before and after busulfan conditioning and beti-cel infusion
. | Before busulfan conditioning and beti-cel infusion . | After busulfan conditioning and beti-cel infusion . | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Patient 1 . | Patient 2 . | Patient 3 . | Patient 6 . | Patient 8 . | Patient 1 . | Patient 2 . | Patient 3 . | Patient 6 . | Patient 8 . | |
LH, U/L (normal, 0.79-11.75) | 1.4 | 7.86 | n.a. | 4.24 | 0.47 | 6 | 8.94 | 6.87 | 6.36 | 0.52 |
FSH, U/L (normal, 1.08-12.85) | 2.2 | 4.99 | n.a. | 12.8 | 0.81 | n.a. | 9.38 | 9.94 | 12.05 | 3.08 |
Testosterone, ng/mL (normal, 2-7) | n.a. | n.a. | n.a. | 6.83 | n.a. | 4.4 | 3.44 | 5.54 | 0.98 | 5 |
Inhibin B, ng/L (normal, >120) | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | 20 | 487 | 10 | 122 |
. | Before busulfan conditioning and beti-cel infusion . | After busulfan conditioning and beti-cel infusion . | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Patient 1 . | Patient 2 . | Patient 3 . | Patient 6 . | Patient 8 . | Patient 1 . | Patient 2 . | Patient 3 . | Patient 6 . | Patient 8 . | |
LH, U/L (normal, 0.79-11.75) | 1.4 | 7.86 | n.a. | 4.24 | 0.47 | 6 | 8.94 | 6.87 | 6.36 | 0.52 |
FSH, U/L (normal, 1.08-12.85) | 2.2 | 4.99 | n.a. | 12.8 | 0.81 | n.a. | 9.38 | 9.94 | 12.05 | 3.08 |
Testosterone, ng/mL (normal, 2-7) | n.a. | n.a. | n.a. | 6.83 | n.a. | 4.4 | 3.44 | 5.54 | 0.98 | 5 |
Inhibin B, ng/L (normal, >120) | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | 20 | 487 | 10 | 122 |